Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757651 | SCV000885952 | likely benign | Polycystic kidney disease, adult type | 2018-07-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001563042 | SCV001785916 | likely benign | not provided | 2021-02-16 | criteria provided, single submitter | clinical testing | Has been previously published as a known polymorphic variant in a supplemental table (Rossetti et al., 2012); This variant is associated with the following publications: (PMID: 22383692) |
Ce |
RCV001563042 | SCV002545731 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | PKD1: BP4 |
Ambry Genetics | RCV002533809 | SCV003695037 | likely benign | Inborn genetic diseases | 2022-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |